MYD88 and hepatocellular carcinoma: To examine whether the inhibition of TLR4/MyD88 mediated the in vivo anti‐HCC effect of geniposide, orthotopic HCC mice were co‐treated with geniposide and LPS (3 mg·kg−1 per single injection; n = 5 per group).